REdI Conference
The Regulatory Education for Industry (REdI) Program is an FDA-led forum that brings together the regulatory educators from the FDA's medical product centers: Center for Drug Evaluation and Research (CDER), Center for Devices and Radiological Health (CDRH), and Center for Biologics Evaluation and Research (CBER). There is no cost to register or attend the conference.
Goal:
To provide direct, relevant, and helpful information on the key aspects of drug, device, and biologics regulations.
Audience:
Small manufacturers, researchers, and innovators seeking to learn about how the FDA regulates drugs, devices, and biologics medical products.
Program Series and Format:
- The conference is offered in a hybrid format, with both virtual and in-person presentations.
- For each FDA medical product center, REdI features a plenary session that combines the themes of drugs (CDER), devices (CDRH), and biologics (CBER) regulatory policy.
- Topics span total product lifecycle.